0.0(top 100%)
impact factor
490(top 50%)
papers
213(top 50%)
citations
5(top 50%)
h-index
0.0(top 100%)
impact factor
553
all documents
232
doc citations
9(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1THE COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS OF INTRAOCULAR 90Sr BRACHYTHERAPY/INTRAVITREAL VEGF INHIBITOR FOR NEOVASCULAR MACULAR DEGENERATIONEvidence-Based Ophthalmology200920
2FALLS AND HEALTH STATUS IN ELDERLY WOMEN FOLLOWING FIRST EYE CATARACT SURGERY: A RANDOMIZED CONTROLLED TRIALEvidence-Based Ophthalmology200510
3VALUE-BASED MEDICINE'S COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS ANALYSESEvidence-Based Ophthalmology201110
4THE SEVENTH REPORT OF THE JOINT NATIONAL COMMITTEE ON PREVENTION, DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD PRESSURE: THE JNC REPORTEvidence-Based Ophthalmology20066
5THE RESTORE STUDYEvidence-Based Ophthalmology20116
6RISK FACTORS FOR CHOROIDAL NEOVASCULARIZATION AND GEOGRAPHIC ATROPHY IN THE COMPLICATIONS OF AGE-RELATED MACULAR DEGENERATION PREVENTION TRIALEvidence-Based Ophthalmology20096
7COMPARATIVE EFFECTIVENESS AND TRANSLATIONAL MEDICINEEvidence-Based Ophthalmology20085
8CLINICAL CHARACTERISTICS OF HYDROXYCHLOROQUINE RETINOPATHYEvidence-Based Ophthalmology20115
9TREATMENT OF POSTERIOR UVEITIS WITH A FLUOCINOLONE ACETONIDE IMPLANTEvidence-Based Ophthalmology20095
10PUBLISHED INTERNATIONAL CLASSIFICATION OF RETINOBLASTOMA (ICRB) DEFINITIONS CONTAIN INCONSISTENCIES: AN ANALYSIS OF IMPACTEvidence-Based Ophthalmology20094
11OUTBREAK OF ACQUIRED OCULAR TOXOPLASMOSIS INVOLVING 248 PATIENTSEvidence-Based Ophthalmology20104
12RANDOMIZED TRIAL EVALUATING RANIBIZUMAB PLUS PROMPT OR DEFERRED LASER OR TRIAMCINOLONE PLUS PROMPT LASER FOR DIABETIC MACULAR EDEMAEvidence-Based Ophthalmology20104
13VALUE-BASED MEDICINE, COST-UTILITY ANALYSISEvidence-Based Ophthalmology20094
14PHYSICIANS AND NURSES ARE ECONOMIC VALUE PRODUCERSEvidence-Based Ophthalmology20064
15THE RELATIONSHIP OF DIETARY CAROTENOID AND VITAMIN A, E, AND C INTAKE WITH AGE-RELATED MACULAR DEGENERATION IN A CASE-CONTROL STUDY AREDS REPORT NO. 22Evidence-Based Ophthalmology20083
16PREVALENCE OF DIABETIC RETINOPATHY IN INDIA: SANKARA NETHRALAYA DIABETIC RETINOPATHY EPIDEMIOLOGY AND MOLECULAR GENETICS STUDY REPORT 2Evidence-Based Ophthalmology20093
17TOPICAL CYCLOSPORINE (RESTASIS) COST-UTILITY ANALYSISEvidence-Based Ophthalmology20093
18PRIMARY END POINT (SIX MONTHS) RESULTS OF THE RANIBIZUMAB FOR EDEMA OF THE MACULA IN DIABETES (READ-2) STUDYEvidence-Based Ophthalmology20103
19A RANDOMIZED TRIAL COMPARING THE EFFICACY AND SAFETY OF INTRAVITREAL TRIAMCINOLONE WITH STANDARD CARE TO TREAT VISION LOSS ASSOCIATED WITH MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSIONEvidence-Based Ophthalmology20103
20WHAT'S IN STORE?Evidence-Based Ophthalmology20113
21CENTRAL RETINAL ARTERY OCCLUSIONEvidence-Based Ophthalmology20113
22FLUOCINOLONE ACETONIDE IMPLANT (RETISERT) FOR NONINFECTIOUS POSTERIOR UVEITIS: THIRTY-FOUR–WEEK RESULTS OF A MULTICENTER RANDOMIZED CLINICAL STUDYEvidence-Based Ophthalmology20063
23RANDOMIZED CONTROLLED STUDY OF AN INTRAVITREOUS DEXAMETHASONE DRUG DELIVERY SYSTEM IN PATIENTS WITH PERSISTENT MACULAR EDEMAEvidence-Based Ophthalmology20073
24VALUE-BASED MEDICINE, COST-UTILITY ANALYSISEvidence-Based Ophthalmology20083
25THE BOSTON TYPE 1 KERATOPROSTHESIS: IMPROVING OUTCOMES AND EXPANDING INDICATIONSEvidence-Based Ophthalmology20093
26COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS ANALYSESEvidence-Based Ophthalmology20103
27THE COMS RANDOMIZED TRIAL OF IODINE 125 BRACHYTHERAPY FOR CHOROIDAL MELANOMA V. TWELVE-YEAR MORTALITY RATES AND PROGNOSTIC FACTORS: COMS REPORT NO. 28Evidence-Based Ophthalmology20072
28EDITORIAL: MADE TO ORDEREvidence-Based Ophthalmology20082
29RISK OF ADVANCED AGE-RELATED MACULAR DEGENERATION AFTER CATARACT SURGERY IN THE AGE-RELATED EYE DISEASE STUDY: AREDS REPORT 25Evidence-Based Ophthalmology20092
30A RANDOMIZED, MASKED COMPARISON OF TOPICAL KETOROLAC 0.4% PLUS STEROID VERSUS STEROID ALONE IN LOW-RISK CATARACT SURGERY PATIENTSEvidence-Based Ophthalmology20092
31PATCHING VS ATROPINE TO TREAT AMBLYOPIA IN CHILDREN AGED 7 TO 12 YEARSEvidence-Based Ophthalmology20092
32A VARIABLE-DOSING REGIMEN WITH INTRAVITREAL RANIBIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: YEAR 2 OF THE PRONTO STUDYEvidence-Based Ophthalmology20102
33A RANDOMIZED TRIAL COMPARING THE EFFICACY AND SAFETY OF INTRAVITREAL TRIAMCINOLONE WITH OBSERVATION TO TREAT VISION LOSS ASSOCIATED WITH MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION THE STANDARD CARE VERSUS CORTICOSTEROID FOR RETINAL VEIN OCCLUSION (SCORE) STUDY REPORT 5Evidence-Based Ophthalmology20102
34THE 25-YEAR INCIDENCE OF VISUAL IMPAIRMENT IN TYPE 1 DIABETES MELLITUSEvidence-Based Ophthalmology20112
35YAG LASER PERIPHERAL IRIDOTOMY FOR THE PREVENTION OF PIGMENT DISPERSION GLAUCOMAEvidence-Based Ophthalmology20112
36NON-STEROIDAL ANTI-INFLAMMATORY AGENTS FOR CYSTOID MACULAR EDEMA FOLLOWING CATARACT SURGERY: A SYSTEMATIC REVIEWEvidence-Based Ophthalmology20062
37COGNITIVE IMPAIRMENT IN THE AGE-RELATED EYE DISEASE STUDYEvidence-Based Ophthalmology20062
38DETECTION OF EARLY HYDROXYCHLOROQUINE RETINAL TOXICITY ENHANCED BY RING RATIO ANALYSIS OF MULTIFOCAL ELECTRORETINOGRAPHYEvidence-Based Ophthalmology20082
39CHOROIDAL NEVUS TRANSFORMATION INTO MELANOMAEvidence-Based Ophthalmology20102
40VALUE-BASED MEDICINE COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS ANALYSESEvidence-Based Ophthalmology20112
41A SYSTEM FOR PREOPERATIVE STRATIFICATION OF CATARACT PATIENTS ACCORDING TO RISK OF INTRAOPERATIVE COMPLICATIONS: A PROSPECTIVE ANALYSIS OF 1441 CASESEvidence-Based Ophthalmology20051
42DIABETIC RETINOPATHY IN A MULTI-ETHNIC COHORT IN THE UNITED STATESEvidence-Based Ophthalmology20061
43RANIBIZUMAB COMBINED WITH VERTEPORFIN PHOTODYNAMIC THERAPY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: YEAR 1 RESULTS OF THE FOCUS STUDYEvidence-Based Ophthalmology20071
44A PROSPECTIVE RANDOMIZED TRIAL OF DIFFERENT DOSES OF INTRAVITREAL TRIAMCINOLONE FOR DIABETIC MACULAR EDEMAEvidence-Based Ophthalmology20071
45IMPACT OF THE DESCEMET MEMBRANE PERFORATION ON SURGICAL OUTCOMES AFTER DEEP LAMELLAR KERATOPLASTYEvidence-Based Ophthalmology20071
46EFFECT OF RUBOXISTAURIN IN PATIENTS WITH DIABETIC MACULAR EDEMA: THIRTY-MONTH RESULTS OF THE RANDOMIZED PKC-DMES CLINICAL TRIALEvidence-Based Ophthalmology20071
47MIDLIFE RISK FACTORS AND HEALTHY SURVIVAL IN MENEvidence-Based Ophthalmology20071
48REVIEW: SAMPLE SIZE CALCULATIONEvidence-Based Ophthalmology20081
49MANAGEMENT OF DIABETIC RETINOPATHY: A SYSTEMATIC REVIEWEvidence-Based Ophthalmology20081
50C-REACTIVE PROTEIN LEVEL AND RISK OF AGING MACULA DISORDEREvidence-Based Ophthalmology20081